• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

InVivo Therapeutics Holdings Corp

+ Add to Watchlist


1.4400 USD 0.0500 3.60%

As of 20:10:04 ET on 12/26/2014.

Snapshot for InVivo Therapeutics Holdings Corp (NVIV)

Open: 1.3850 Day's Range: 1.3800 - 1.4700 Volume: 298,253
Previous Close: 1.3900 52wk Range: 0.4651 - 2.6700 1-Yr Rtn: -40.25%

Stock Chart for NVIV

No chart data available.
  • NVIV:US 1.4400
  • 1D
  • 1M
  • 1Y
Interactive NVIV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVIV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1573
Est. EPS (USD) (12/2014) -0.2000
Est. PEG Ratio -
Market Cap (M USD) 134.71
Shares Outstanding (M) 93.55
30 Day Average Volume 595,633
Price/Book (mrq) 9.9415
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/17/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVIV

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVIV

InVivo Therapeutics Holdings Corp., through its subsidiary, is a medical device company. The Company is focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury.

Mark D PerrinChief Executive OfficerSteven McAllister "Steve"Chief Financial Officer
Thomas R UlichChief Scientific OfficerTamara L JosephSenior VP/Chief Compliance Ofcr
More Company Profile & Key Executives for NVIV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil